United Therapeutics Corp (UTHR)
233.85
-2.10
(-0.89%)
USD |
NASDAQ |
Apr 26, 16:00
233.75
-0.10
(-0.04%)
After-Hours: 20:00
United Therapeutics Price to Book Value: 1.839 for April 26, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 26, 2024 | 1.839 |
| April 25, 2024 | 1.855 |
| April 24, 2024 | 1.864 |
| April 23, 2024 | 1.844 |
| April 22, 2024 | 1.840 |
| April 19, 2024 | 1.871 |
| April 18, 2024 | 1.863 |
| April 17, 2024 | 1.850 |
| April 16, 2024 | 1.822 |
| April 15, 2024 | 1.848 |
| April 12, 2024 | 1.829 |
| April 11, 2024 | 1.865 |
| April 10, 2024 | 1.870 |
| April 09, 2024 | 1.864 |
| April 08, 2024 | 1.863 |
| April 05, 2024 | 1.836 |
| April 04, 2024 | 1.839 |
| April 03, 2024 | 1.818 |
| April 02, 2024 | 1.797 |
| April 01, 2024 | 1.795 |
| March 28, 2024 | 1.806 |
| March 27, 2024 | 1.913 |
| March 26, 2024 | 1.949 |
| March 25, 2024 | 1.921 |
| March 22, 2024 | 1.871 |
| Date | Value |
|---|---|
| March 21, 2024 | 1.863 |
| March 20, 2024 | 1.861 |
| March 19, 2024 | 1.882 |
| March 18, 2024 | 1.840 |
| March 15, 2024 | 1.854 |
| March 14, 2024 | 1.872 |
| March 13, 2024 | 1.897 |
| March 12, 2024 | 1.941 |
| March 11, 2024 | 1.962 |
| March 08, 2024 | 1.911 |
| March 07, 2024 | 1.887 |
| March 06, 2024 | 1.863 |
| March 05, 2024 | 1.807 |
| March 04, 2024 | 1.799 |
| March 01, 2024 | 1.824 |
| February 29, 2024 | 1.774 |
| February 28, 2024 | 1.787 |
| February 27, 2024 | 1.783 |
| February 26, 2024 | 1.758 |
| February 23, 2024 | 1.785 |
| February 22, 2024 | 1.711 |
| February 21, 2024 | 1.723 |
| February 20, 2024 | 1.684 |
| February 16, 2024 | 1.688 |
| February 15, 2024 | 1.687 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.253
Minimum
Mar 18 2020
2.802
Maximum
Dec 09 2022
1.986
Average
1.992
Median
Dec 07 2023
Price to Book Value Benchmarks
| Liquidia Corp | 20.14 |
| Esperion Therapeutics Inc | -- |
| Vertex Pharmaceuticals Inc | 5.840 |
| Heron Therapeutics Inc | -- |
| Aldeyra Therapeutics Inc | 1.932 |
Price to Book Value Related Metrics
| PE Ratio | 11.79 |
| PS Ratio | 4.994 |
| PEG Ratio | 0.3673 |
| Price to Free Cash Flow | 15.55 |
| Price | 233.85 |
| Earnings Yield | 8.48% |
| Market Cap | 11.00B |
| PEGY Ratio | 0.3673 |
| Operating PE Ratio | 9.809 |
| Normalized PE Ratio | 11.79 |